Hyperbaric oxygen: Its application in cardiology a historical perspective and personal journey

Cardiology in Review

Volumn 17, Issue 6, 2009, Pages 280-282

  Ellestad, Myrvin H ^a  

^a Memorial Heart & Vascular Institute   (United States)

Author keywords

Heart Attacks; Hyperbaric oxygen; Ischemic reperfusion injury

Indexed keywords

ADENOSINE; ERYTHROPOIETIN; FIBRINOLYTIC AGENT; HYDROGEN SULFIDE; KAI 9803; PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; BLOOD CLOT LYSIS; CELL DEATH; CONGENITAL HEART DISEASE; CORONARY ARTERY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART SURGERY; HUMAN; HYPERBARIC OXYGEN; NONHUMAN; OXYGENATOR; REPERFUSION INJURY; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; WOUND HEALING; CARDIOVASCULAR SURGERY; CORONARY ARTERY DISEASE; HEART INFARCTION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR SURGICAL PROCEDURES; CORONARY ARTERY DISEASE; HUMANS; HYPERBARIC OXYGENATION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY;

EID: 73949158869     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/CRD.0b013e3181bad02d     Document Type: Review

References (16)

1. Boerema I, Meijne NG, Brummelkamp WH, et al. Life without blood. J Cardiovasc Surg. 1960;1:133-146.
2. Meijne NG, Bulterijs A, Eloff SJ. An experimental investigation into the influence of administration of oxygen under increased atmospheric pressure upon coronary infarction. J Cardiov Surg. 1063;4:521-525.
3. Shandling AH, Ellestad MH, Hart GB, et al. Hyperbaric oxygen and thrombolysis in myocardial infarction. Am Heart J. 1997;134:544-550
4. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
5. Hernandez KA, Grisham MB, Twohig B, et al. Role of neutrophils in ischemia reperfusion-induced microvascular injury. Am J Physiol. 1987;253: H699-H703.
6. Ma X-L, Lefer DJ, Lefer AM, et al. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation. 1992;86:937-946.
7. Sterling DL, Thornton JF, Swafford A, et al. Hyperbaric oxygen limits infarct size in ischemic rabbit myocardium in vivo. Circulation. 1993;88:1931-1936.
8. Imlay JA, Linn S. DNA damage and oxygen radical toxicity. Science. 1988;240:1302-1309.
9. Rothlein R, Dustin M, Martin SD, et al. A human intercellular adhesion molecule (ICAM-1) distinct from LTA-1. J Immunol 1986;137:1270-1274.
10. Spears JR, Prcevski P, Jiang A, et al. Intracoronary aqueous oxygen perfusion, performed 24 h after the onset of postinfarction reperfusion, experimentally reduces infarct size and improves left ventricular function. Int J Cardiol. 2006;113:371-375.
11. Warda HM, Bax JJ, Bosch JG, et al. Effect of intracoronary aqueous oxygen on left ventricular remodeling after anterior wall ST-elevation acute myocardial infarction. Am J Cardiol. 2005;96:22-24.
12. Dixon SR, Bartorelli AL, Marcovitz PA, et al. Initial experience with hyperoxemic reperfusion after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2002;39:387-392.
13. Stone GW, Spears JR, O'Niel WW. Amihot II: Infarct size reduction with supersaturated oxygen. Cardiovasc Interv. In press.
14. Burns RJ, Gibbons RJ, Yi Q; the CORE Study Investigators. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol. 2002 39:30-36.
15. Hoole SP, Heck PM, Sharples L, et al. Cardiac remote ischemic preconditioning in coronary stenting (CRISP stent) study: a prospective, randomized control trial. Circulation. 2009;119:820-827.
16. Ishii H, Amano T, Matsubara T, et al. Pharmacological intervention for prevention of left ventricular remodeling and improving prognosis in myocardial infarction. Circulation. 2008;118:2710-2718.